About 150,000 people are newly diagnosed with colorectal cancer every year, making the disease the third most common cancer in the U.S. The American Cancer Society estimates that in 2026, more than ...
Researchers from Shuttle Pharmaceuticals LLC and Georgetown University have described the in vitro and in vivo profile of SP-1-303, designed as a dual-function histone deacetylase (HDAC) inhibitor and ...
Researchers at Rockefeller University have identified a signaling loop between breast cancer cells and sensory neurons that promoted tumor metastasis, and showed that in animal models, treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results